These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 10659586

  • 1. [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain].
    Takano K, Matsumura K, Watanabe Y, Yamada T, Kubo H, Naitou Y, Narita Y, Kuzuhara S, Takeda K.
    Kaku Igaku; 1999 Dec; 36(9):1013-22. PubMed ID: 10659586
    [Abstract] [Full Text] [Related]

  • 2. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
    Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T.
    J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
    [Abstract] [Full Text] [Related]

  • 3. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA.
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [Abstract] [Full Text] [Related]

  • 4. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB.
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC.
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
    Nikolaus S, Wirrwar A, Antke C, Arkian S, Schramm N, Müller HW, Larisch R.
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
    [Abstract] [Full Text] [Related]

  • 9. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA.
    Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871
    [Abstract] [Full Text] [Related]

  • 10. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers.
    Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA.
    Eur J Nucl Med; 2000 Jul; 27(7):867-9. PubMed ID: 10952500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A, Zannetti A, Pappatà S, Albanese S, Coda AR, Ragucci M, Nardelli A, Brunetti A, Cuocolo A, Salvatore M.
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.
    Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, van Royen EA.
    Eur J Nucl Med; 1997 Jan; 24(1):68-71. PubMed ID: 9044880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
    Booij J, Hemelaar TG, Speelman JD, de Bruin K, Janssen AG, van Royen EA.
    J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746
    [Abstract] [Full Text] [Related]

  • 20. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M, Baldwin RM, Malison RT, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Sybirska EH, Zimmermann RC, Wisniewski G, Neumeyer JL.
    Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.